Mascoma Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-31
Closed -$463 527
2024
Q4
$463 Buy
31
+30
+3,000% +$489 ﹤0.01% 507
2024
Q3
$19 Hold
1
﹤0.01% 454
2024
Q2
$21 Buy
+1
New +$20 ﹤0.01% 490
2023
Q2
Sell
-6
Closed -$148 556
2023
Q1
$148 Hold
6
﹤0.01% 587
2022
Q4
$168 Hold
6
﹤0.01% 616
2022
Q3
$0 Hold
6
﹤0.01% 618
2022
Q2
$0 Sell
6
-16
-73% -$560 ﹤0.01% 629
2022
Q1
$1K Sell
22
-10
-31% -$342 ﹤0.01% 573
2021
Q4
$1K Buy
32
+1
+3% +$33 ﹤0.01% 519
2021
Q3
$1K Buy
+31
New +$992 ﹤0.01% 435

Other funds holding OGN

Mascoma Wealth Management's OGN Position: Q1 2025 in Review

Mascoma Wealth Management sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 31 shares — an estimated $463 sold.

Mascoma Wealth Management first reported a position in OGN in Q3 2021 and held it in 10 quarters. The position peaked at $1K in Q1 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Mascoma Wealth Management reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Mascoma Wealth Management sold 31 Organon & Co shares in Q1 2025, an estimated $463.
  • Mascoma Wealth Management first reported a position in Organon & Co in Q3 2021 and held it in 10 quarters.
  • Mascoma Wealth Management's Organon & Co position peaked at $1K in Q1 2022.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Mascoma Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.